Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Open in API
Filings indexed 830 across all filing types
Latest filing 2026-05-26 Capital/Financing Update
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
No Deviation or Variation in the use of proceeds raised through the Right Issue.
Capital/Financing Update Classification · 85% confidence The document is a formal compliance statement under SEBI LODR by Sadhana Nitro Chem Ltd reporting on the utilization of funds raised through a Rights Issue. It details the original and actual use of proceeds and confirms no deviation. This is a follow-up on a capital-raising event (Rights Issue) rather than the initial announcement of results, audit, or financial report itself. Therefore it is best classified as a Capital/Financing Update (CAP).
2026-05-26 English
Statement of deviation(s) or variation(s) under Reg. 32
Capital/Financing Update Classification · 65% confidence The document is a SEBI-mandated compliance disclosure submitted to stock exchanges detailing the statement of deviation or variation in utilization of proceeds raised via a Rights Issue. It is neither an earnings report nor management change, but an update on the fundraising proceeds usage. This best fits the Capital/Financing Update category, which covers updates on fundraising or financing activities.
2026-05-26 English
Outcome of Board Meeting
Regulatory Filings Classification · 85% confidence The document is clearly an outcome of a Board Meeting filed under Regulation 30 of SEBI (LODR) Regulations, to stock exchanges (BSE & NSE). It is not an Annual Report (10-K), nor an interim financial report per se, but a compliance announcement containing the audited financial results, auditor’s report and disclosures per listing requirements. Such filings under Regulation 30/33 are captured under General Regulatory Filings (RNS), which is the catch-all for stock exchange compliance announcements that do not fit into other specialized categories.
2026-05-26 English
Audited Standalone & Consolidated Financial Results for Quarter and Year Ended March 31, 2026
Regulatory Filings Classification · 80% confidence The document is a formal SEBI LODR Regulation 30 filing informing stock exchanges of the outcome of a Board meeting. It primarily discloses the board’s approval of the audited financial results, appointment of auditors, and related corporate actions. It is not a standalone annual report (10-K), nor solely an interim report (even though it contains quarterly results), but a regulatory announcement under listing regulations. It does not fit other specific categories (e.g., remuneration, M&A, dividends). Therefore it is best classified as a general regulatory filing.
2026-05-26 English
Outcome of Board Meeting held on May 26, 2026
Regulatory Filings Classification · 85% confidence The document is an announcement of the outcome of the Board Meeting under SEBI LODR Regulation 30, filed with stock exchanges. It contains board resolutions (approval of audited results, auditor appointments, committee changes) and encloses the audit report and financial results. It is not a full annual report or standalone interim report, nor simply a publication notice. It is a general regulatory announcement under listing rules.
2026-05-26 English
Outcome of Board Meeting
Audit Report / Information Classification · 86% confidence The document is not an Annual Report (10-K) or mere earnings release; it is the outcome of a SEBI-mandated board meeting under Regulation 30 that attaches the audited standalone and consolidated financial results along with the independent auditor’s report thereon. This is not a proxy or dividend notice, nor a change of director, but a standalone audit report on the company’s financial results. Accordingly, it fits the “Audit Report / Information” category (AR). FY 2026
2026-05-26 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.